[Federal Register Volume 59, Number 105 (Thursday, June 2, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-13398]
[[Page Unknown]]
[Federal Register: June 2, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Application
Pursuant to section 1301.43(a) of title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 15, 1994, Radian
Corporation, 8501 Mopac Blvd., P.O. Box 201088, Austin, Texas 78720,
made application to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Schedule
------------------------------------------------------------------------
Drug:
Cathinone (1235).......................................... I
Methcathinone (1237)...................................... I
Aminorex (1585)........................................... I
4-Methylaminorex (cis isomer) (1590)...................... I
Methaqualone (2565)....................................... I
Ibogaine (7260)........................................... I
Lysergic acid diethylamide (7315)......................... I
Tetrahyrocannabinols (7370)............................... I
Mescaline (7381).......................................... I
3,4-Methylenedioxyamphetamine (7400)...................... I
3,4-Methylenedioxy-N-ethylamphetamine (7404).............. I
3,4-Methylenedioxymethamphetamine (7405).................. I
4-Methoxyamphetamine (7411)............................... I
Heroin (9200)............................................. I
Normorphine (9313)........................................ I
Acetylmethadol (9601)..................................... I
3-Methylfentanyl (9813)................................... I
Amphetamine (1100)........................................ II
Methamphetamine (1105).................................... II
Methylphenidate (1724).................................... II
Amobarbital (2125)........................................ II
Pentobarbital (2270)...................................... II
Secobarbital (2315)....................................... II
Phencyclidine (7471)...................................... II
Oxycodone (9143).......................................... II
Hydromorphone (9150)...................................... II
Benzoylecgonine (9180).................................... II
Hydrocodone (9193)........................................ II
Meperidine (9230)......................................... II
Methadone (9250).......................................... II
Morphine (9300)........................................... II
Oxymorphone (9652)........................................ II
Alfentanil (9737)......................................... II
Sufentanil (9740)......................................... II
Fentanyl (9801)........................................... II
------------------------------------------------------------------------
The firm plans to manufacture deuterated material for use in exempt
products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application and may also file a written
request for a hearing thereon in accordance with 21 CFR 1301.54 and in
the form prescribed by 21 CFR 1316.47.
Any such comments, objections, or requests for a hearing may be
addressed to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, DC 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than July 5, 1994.
Dated: May 23, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 94-13398 Filed 6-1-94; 8:45 am]
BILLING CODE 4410-09-M
